Shares of drug major Cipla today trimmed most of its early gains on profit-booking and ended nearly 2 per cent higher.
The stock settled at Rs 532.75, up 1.60 per cent on BSE. During the day, it surged 7.27 per cent to Rs 562.50.
At NSE, shares of the company rose 1.90 per cent to end at Rs 534.
In terms of equity volume, 4 lakh shares of the company were traded on BSE and over 74 lakh shares changed hands at NSE during the day.
Cipla yesterday reported a consolidated net profit of Rs 153.25 crore for the quarter ended March 31, on account of robust sales in key markets and reduction in expenses.
The company had posted a net loss of Rs 62.79 crore during January-March, 2016-17, Cipla said in a BSE filing.
Total income from operations stood at Rs 3,697.97 crore. It was Rs 3,582 crore for the same period a year ago.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app